BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.220
-0.050 (-3.94%)
Jan 14, 2026, 12:43 PM EST - Market open
BioVie Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for BioVie in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for BioVie.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| ThinkEquity | ThinkEquity | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +24,490.16% | Jul 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,200 → $500 | Buy | Maintains | $1,200 → $500 | +40,883.61% | Nov 30, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +90,063.93% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +90,063.93% | Jul 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1,100 | Buy | Reiterates | $1,100 | +90,063.93% | May 17, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.01
from -12.12
EPS Next Year
n/a
from -3.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| High | n/a | n/a | ||
| Avg | n/a | n/a | ||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -3.10 |
| Avg | -3.01 |
| Low | -2.89 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.